Drugmaker
Endo is contemplating its options after peers including
Conversations with advisers Skadden, PJT and advisory firm
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.